Stifel Nicolaus Summary

Loading...
Loading...
Stifel Nicolaus is upgrading iStar Financial
SFI
to Buy. It is also upgrading Newcastle Investment
NCT
to Buy. It is increasing the target price on Endo Pharmaceuticals
ENDP
to $53.00 from $45.00. Estimates are increased on iStar Financial and Newcastle Investment, and coverage is discontinued on Tree.com
TREE
.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorUpgradesPrice TargetAnalyst Ratingsendo pharmaceuticalsFinancialsHealth CareiStar Financial Inc. (SFI)Mortgage REIT'snewcastle investmentPharmaceuticalsStifel NicolausThrifts & Mortgage Financetree.com
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...